Cancer Communications
indexed by SCI

About the cover
About the cover

Jul. 2013; Volume 32 Issue 7

In July 2000, the US FDA approved tamoxifen to reduce the risk of invasive breast cancer in women with ductal carcinoma in situ (DCIS) following breast surgery and radiation. Tamoxifen is the first medication to be approved for DCIS, which accounts for nearly 20 percent of all newly diagnosed breast cancer cases. From The Coming Cancer Breakthroughs.

Conference Report
Translational Research in Oncology Research & Development and Its Impact on Early Development in China: report of the 5th Annual Meeting of the US Chinese Anti-Cancer Association (USCACA) at 2013 AACR Annual Meeting
Lingjie Guan, Yun Dai, Roger Luo
[ Abstract  2367]   [ PDF Full-text  2202]     [ PubMed ]  Page: 357-362  Epub: 2013-7-1  doi: 10.5732/cjc.013.10115
Targeted therapy: tailoring cancer treatment
Min Yan, Quentin Qiang Liu
[ Abstract  2417]   [ PDF Full-text  2178]     [ PubMed ]  Page: 363-364  Epub: 2013-7-1  doi: 10.5732/cjc.013.10114
Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance
Ana R. Gomes, Fung Zhao, Eric W.F. Lam
[ Abstract  3829]   [ PDF Full-text  5149]     [ HTML PMC ]  Page: 365-370  Epub: 2013-5-27  doi: 10.5732/cjc.012.10277
Mouse models of Mdm2 and Mdm4 and their clinical implications
Shunbin Xiong
[ Abstract  3262]   [ PDF Full-text  4284]     [ HTML PMC ]  Page: 371-375  Epub: 2013-1-18  doi: 10.5732/cjc.012.10286
Molecular mechanisms of tumor resistance to PI3K-mTOR-targeted therapy
Jing Tan, Qiang Yu
[ Abstract  3472]   [ PDF Full-text  4156]     [ HTML PMC ]  Page: 376-379  Epub: 2013-5-14  doi: 10.5732/cjc.012.10287
Skeletal metastasis: treatments, mouse models, and the Wnt signaling
Kenneth C. Valkenburg, Matthew R. Steensma, Bart O. Williams , Zhendong Zhong
[ Abstract  3763]   [ PDF Full-text  5164]     [ HTML PMC ]  Page: 380-396  Epub: 2013-1-18  doi: 10.5732/cjc.012.10218
Original Article
Volumetric modulation arc radiotherapy with flattening filter-free beams compared with conventional beams for nasopharyngeal carcinoma: a feasibility study
Mingzan Zhuang, Tuodan Zhang, Zhijian Chen, Zhixiong Lin, Derui Li, Xun Peng, Qingchun Qiu, Renhua Wu
[ Abstract  3909]   [ PDF Full-text  4781]     [ HTML PMC ]  Page: 397-402  Epub: 2012-12-14  doi: 10.5732/cjc.012.10182
Overexpression of Cdc25C predicts response to radiotherapy and survival in esophageal squamous cell carcinoma patients treated with radiotherapy followed by surgery
Bao-Zhong Li, Zhao-Li Chen, Su-Sheng Shi, Xiao-Li Feng, Xiao-Gang Tan, Fang Zhou, Jie He
[ Abstract  2202]   [ PDF Full-text  2572]     [ HTML PMC ]  Page: 403-409  Epub: 2013-3-8  doi: 10.5732/cjc.012.10233
Brief Report
The absence of the ERBB4 hotspot mutations in melanomas in patients from southern China
Qi-Ming Zhou, Wei Li, Yuan-Xiang Guan, Xing Zhang, Xin-Chun Chen, Ya Ding, Xi-Zhi Wen, Rui-Qing Peng, Shu-Mei Yan, Xiao-Shi Zhang
[ Abstract  2551]   [ PDF Full-text  2885]     [ HTML PMC ]  Page: 410-414  Epub: 2012-12-14  doi: 10.5732/cjc.012.10121
Case Research
Malignant meningioma of the cerebellopontine angle in a 2-year-old girl: a case report and literature review
Ming-Chao Fan, Xin Zhang, Qiao-Ling Wang, Lei Cheng, Cai-Yun Dai, Dan Yu , Peng Sun
[ Abstract  2232]   [ PDF Full-text  2852]     [ HTML PMC ]  Page: 415-417  Epub: 2013-3-8  doi: 10.5732/cjc.012.10211

CC Wechat 微信公众号


Editorial Manager

CC adopts Editorial Manager to manage its submissions from Dec.18, 2014


Reference style for  

 Reference Manager

Editorial Manager





Advanced search


CJC is now published by BioMed Central

© Chinese Journal of Cancer

Sun Yat-sen University Cancer Center

651 Dongfeng Road East, Guangzhou 510060, P. R. China